Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis.

Abstract

BACKGROUND Naproxen strongly inhibits platelet aggregation. OBJECTIVE To examine the risk of acute thromboembolic cardiovascular events (TCEs) (myocardial infarction, sudden death, and stroke) with current naproxen use among patients with rheumatoid arthritis. METHODS We studied patients aged 40 to 79 years with rheumatoid arthritis in the British… (More)

Topics

Cite this paper

@article{Watson2002LowerRO, title={Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis.}, author={Douglas J. Watson and Thomas R. Rhodes and Bing Cai and Harry A. Guess}, journal={Archives of internal medicine}, year={2002}, volume={162 10}, pages={1105-10} }